NASDAQIndustrialsAerospace & DefenseSnapshot 2026-07-31
Reading RCAT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Achieve revenue between $150M and $180M in 2026: revenue guidance $165M vs $150M and $180M target.
View ThesisManagement screens weak on capital allocation, earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 766% growth a year, above the roughly 34% analysts expect, leaving little room for error.
View ValuationThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 61% in its worst 12-month stretch.
View RiskRCAT's growth depends on improving its financial performance and stabilizing management. Recent results show weak performance, with a significant miss of 83% last quarter. It trades at 30 times sales, which is much higher than the peer median of 3.5 times. The market seems to expect more growth than is realistic, indicating full expectations. A specific risk is the 64% chance of another earnings miss next quarter. Peer multiples imply a price about 744% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. RCAT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering RCAT (as of Jul 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Advances: Expand through acquisitions
Acquisition expands defense portfolio, aligning with growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Achieve revenue target of $150M-$180M for 2026
AI drone kit tests support revenue growth target.
Advances: Achieve revenue target of $150M-$180M for 2026
Pentagon spending boosts market potential for RCAT.
Advances: Achieve revenue target of $150M-$180M for 2026
Buy initiation indicates confidence in drone demand growth.
Advances: Achieve revenue target of $150M-$180M for 2026
Positioning for leadership supports revenue growth objective.
Advances: Achieve revenue target of $150M-$180M for 2026
Defense contracts and production ramp enhance revenue outlook.
